Fetoscopic endoluminal tracheal occlusion (FETO) and bilateral congenital diaphragmatic hernia
2023

Fetoscopic Treatment for Congenital Diaphragmatic Hernia

publication Evidence: low

Author Information

Author(s): Khawash Adrita, Kronfli Rania, Arasu Anusha, Gandhi Rashmi, Nicolaides Kypros, Greenough Anne

Primary Institution: King’s College London, King’s College Hospital NHS Foundation Trust, London, UK

Hypothesis

Can fetoscopic endoluminal tracheal occlusion (FETO) improve outcomes in infants with bilateral congenital diaphragmatic hernia (CDH)?

Conclusion

FETO can improve prognosis in infants with bilateral CDH.

Supporting Evidence

  • Bilateral congenital diaphragmatic hernias occur in one to two percent of CDH patients.
  • Survival rates for infants with bilateral CDH can be less than 30% due to severe lung hypoplasia.
  • The infant was successfully treated with FETO, leading to improved lung-to-head ratio.

Takeaway

Doctors used a special procedure to help a baby with a serious lung problem before she was born, and it worked well.

Methodology

The fetus underwent fetoscopic endoluminal tracheal occlusion (FETO) to improve lung development.

Limitations

The study is based on a single case report, limiting generalizability.

Participant Demographics

The mother was a 32-year-old woman in her first pregnancy.

Digital Object Identifier (DOI)

10.1515/crpm-2023-0010

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication